Registration Decision RD2020-12, Fluxapyroxad and Xzemplar
This decision is consistent with the Proposed Registration Decision PRD2020-09, Fluxapyroxad and Xzemplar, whichcontains a detailed evaluation of the information submitted in support of this registration.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Registration Decision RD2020-12, Fluxapyroxad and XzemplarHTMLEnglish publication HTML
-
Registration Decision RD2020-12, Fluxapyroxad and XzemplarHTMLFrench publication HTML
Similar records